Speech in children with cerebral palsy

To examine the frequency, characteristics, and factors associated with speech delay and disorder in a community sample of children with cerebral palsy (CP).

Method

Participants were 84 children (37 females, 47 males; aged between 4y 11mo–6y 6mo) with CP identified through a population‐based registry. Speech and oromotor function were systematically evaluated to provide a differential diagnosis of articulation, phonological, and motor speech disorders.

Results

In total, 82% (69/84) of participants had delayed or disordered speech production, including minimally verbal presentations (=20). Verbal participants (=64) presented with dysarthria (78%), articulation delay or disorder (54%), phonological delay or disorder (43%), features of childhood apraxia of speech (CAS) (17%), or mixed presentations across these conditions. Speech intelligibility was poorest in those with dysarthria and features of CAS. Speech delay or disorder in verbal participants was associated with language impairment (=0.002) and reduced health‐related quality of life (=0.04) (Fisher’s exact test). Poorer speech accuracy (i.e. lower percentage consonants correct) correlated with greater impairments in both language (<0.001) and oromotor function (<0.001) (Spearman’s test).

Interpretation

The speech profile of children with CP is characterized by impairment at multiple levels of speech production (phonetic, cognitive‐linguistic, neuromuscular execution, and high‐level planning/programming), highlighting the importance of a personalized differential diagnosis informing targeted treatment.

Click here for more details

 

Related Post

  • Posted on 30 March, 2023
    L16HTHOUSE is a research trial testing an experimental medication for treating speech, motor, learning, and other developmental delays in children...
    • Posted on 30 March, 2023
      Speech and language development is a complex, multifactorial process driven by the individual’s ability to process and formulate communication. These...
      • Posted on 28 November, 2021
        Rare genetically inherited neurodevelopmental disorders remain a huge diagnostic and therapeutic challenge in clinical medicine. Redenlab pediatric consultant Prof Angela...